0.5 Mg-Ml Eribulin Mesylate Solution For Injection

Name: 0.5 Mg-Ml Eribulin Mesylate Solution For Injection
Brand: NEETCO BIOPHARMA
Price: 9000 INR
Availability: InStock

Price 9000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

0.5 Mg-Ml Eribulin Mesylate Solution For Injection Specification

Indication
Metastatic breast cancer, unresectable or metastatic liposarcoma

Dosage Form
Injection

Origin of Medicine
Synthetic

Salt Composition
Eribulin Mesylate 0.5 mg/ml

Pacakaging (Quantity Per Box)
1 Vial per Box

Drug Type

Ingredients
Eribulin Mesylate

Physical Form
Solution For Injection

Function
Anti-cancer medication

Recommended For
Patients of metastatic breast cancer, liposarcoma

Dosage
0.5 mg/ml

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
2 ml Vial

Storage Instructions
Store below 25C, protect from light

About 0.5 Mg-Ml Eribulin Mesylate Solution For Injection

Order today the acclaimed and featured 0.5 mg/ml Eribulin Mesylate Solution For Injection, branded as Eribulin. This anti-cancer medication offers glorious efficacy for adults battling metastatic breast cancer and unresectable or metastatic liposarcoma. With a spectacular clear solution, each synthetic glass vial contains 2 ml-ready for intravenous administration. Manufactured and marketed by a certified distributor, Eribulin's unprecedented formulation, C40H59NO11CH4O3S, is housed in secure packaging, ensuring a shelf life of 24 months. Store below 25C, protected from light, for optimal potency. Dosage is physician-directed.

Site-Specific Application & Material Features

Eribulin Mesylate Solution For Injection is administered intravenously, directly targeting cancerous cells wherever required by prescription. This synthetic, clear solution features Eribulin Mesylate as the active ingredient, designed for adult patients. The robust material feature includes a secure glass vial, maintaining drug purity throughout its shelf life. Used exclusively by healthcare professionals, Eribulin delivers focused therapeutic value for individuals diagnosed with metastatic breast cancer or unresectable liposarcoma.

Supply Ability, Packaging, and Sample Availability

Our supply of Eribulin Mesylate Solution For Injection is reliable, with each box containing one glass vial (2 ml) at 0.5 mg/ml strength. Goods transport is managed with strict protocols to ensure product integrity during transit. Packaging details reflect certified standards for safety and clarity. Sample vials are available for qualified healthcare institutions; charges may apply based on transportation and request. Each shipment is handled professionally to provide you with secure and timely delivery.

FAQ's of 0.5 Mg-Ml Eribulin Mesylate Solution For Injection:

Q: How is Eribulin Mesylate Solution For Injection administered?

A: Eribulin Mesylate Solution For Injection is administered intravenously by qualified healthcare professionals according to your physician's dosage guidelines.

Q: What conditions is Eribulin Solution indicated for?

A: Eribulin Solution is recommended for adults with metastatic breast cancer and unresectable or metastatic liposarcoma, as prescribed by your oncologist.

Q: When should Eribulin Solution be used?

A: Use Eribulin Solution strictly according to your physician's scheduling and dosage instructions, typically in a hospital or clinic setting.

Q: Where can I store Eribulin Mesylate Solution?

A: Store Eribulin Solution below 25C and protect it from light, ensuring the glass vial remains sealed until use.

Q: What is the packaging of Eribulin Mesylate Solution?

A: Each box contains one glass vial (2 ml), clearly labeled with the salt composition and dosage form, adhering to certified packaging standards.

Q: How can samples of Eribulin Solution be requested?

A: Samples may be requested by certified healthcare institutions. Availability is subject to distributor policy, and charges for transportation may apply.

Tell us about your requirement